However, the CAR/CXCR5 T cells were insufficient to reduce HIV-1 VLs in plasma and were unable to prevent CD4+ T-cell loss postinfection, likely because the infused CD4+ CAR/CXCR5+ T cells and nontransduced cells in the product were susceptible to HIV infection. This evidence concerns the gene CXCR5 and HIV infectious disease.